Menu Back toSession 1 : Regulatory Trends in Response to COVID-19

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Session 1 : Regulatory Trends in Response to COVID-19

Session Chair(s)

Hae-Young  Ahn, PhD

Hae-Young Ahn, PhD

  • President
  • Ahn Bio, United States


Peter W. Marks, MD, PhD

Peter W. Marks, MD, PhD

  • Director, Center for Biologics Evaluation and Research
  • FDA, United States
John  Farley, MD, MPH

John Farley, MD, MPH

  • Director, Office of Infectious Diseases, OND, CDER
  • FDA, United States
Thomas  Larsson

Thomas Larsson

  • Scientific Administrator, Community Procedures
  • European Medicines Agency, Netherlands
Gi Hyun  Kim

Gi Hyun Kim

  • Senior Scientific Officer, Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email